BackgroundCheck.run
Search For

Gene D Kinney, 772509 Davis Cir, Sebring, FL 33870

Gene Kinney Phones & Addresses

2509 Davis Cir, Sebring, FL 33870    863-5857120   

267 Lakeview Dr, Sebring, FL 33870   

Columbus, GA   

Antioch, TN   

5450 Lyons Rd, Pompano Beach, FL 33073   

Coconut Creek, FL   

Highland Bch, FL   

Mentions for Gene D Kinney

Publications & IP owners

Us Patents

Treatment Of Movement Disorders With A Metabotropic Glutamate 4 Receptor Positive Allosteric Modulator

US Patent:
2006016, Jul 27, 2006
Filed:
Jul 7, 2004
Appl. No.:
10/564029
Inventors:
P. Conn - Brentwood TN, US
Anthony DiLella - Lansdale PA, US
Gene Kinney - Collegeville PA, US
Michael Marino - Souderton PA, US
Guy Seabrook - Blue Bell PA, US
David Williams - Telford PA, US
International Classification:
A61K 31/5513
A61K 31/551
A61K 31/5415
A61K 31/553
A61K 31/198
A61K 31/445
A61K 31/48
US Classification:
514220000, 514221000, 514225800, 514284000, 514317000, 514567000, 514649000
Abstract:
An mGluR4 receptor positive allosteric modulator is useful, alone or in combination with a neuroleptic agent, for treating or preventing movement disorders such as Parkinson's disease, dyskinesia, tardive dyskinesia, drug-induced parkinsonism, postencephalitic parkinsonism, progressive supranuclear palsy, multiple system atrophy, corticobasal degeneration, parkinsonian-ALS dementia complex, basal ganglia calcification, akinesia, akinetic-rigid syndrome, bradykinesia, dystonia, medication-induced parkinsonian, Gilles de la Tourette syndrome, Huntington's disease, tremor, chorea, myoclonus, tick disorder, and dystonia.

Treatment Of Movement Disorders With A Metabotropic Glutamate 4 Receptor Positive Allosteric Modulator

US Patent:
2010014, Jun 10, 2010
Filed:
Nov 25, 2009
Appl. No.:
12/592499
Inventors:
P. Jeffrey Conn - Brentwood TN, US
Anthony G. DiLella - Lansdale PA, US
Gene G. Kinney - Collegeville PA, US
Michael J. Marino - Souderton PA, US
Guy R. Seabrook - Blue Bell PA, US
David L. Williams - Telford PA, US
International Classification:
A61K 31/352
A61P 25/16
US Classification:
514456
Abstract:
An mGluR4 receptor positive allosteric modulator is useful, alone or in combination with a neuroleptic agent, for treating or preventing movement disorders such as Parkinson's disease, dyskinesia, tardive dyskinesia, drug-induced parkinsonism, postencephalitic parkinsonism, progressive supranuclear palsy, multiple system atrophy, corticobasal degeneration, parkinsonian-ALS dementia complex, basal ganglia calcification, akinesia, akinetic-rigid syndrome, bradykinesia, dystonia, medication-induced parkinsonian, Gilles de la Tourette syndrome, Huntington's disease, tremor, chorea, myoclonus, tick disorder, and dystonia.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.